Key result
Functional mitral regurgitation was not an independent risk factor for the recurrence of paroxysmal atrial fibrillation after catheter ablation (multivariate HR 0.665; 95% CI 0.134-3.300).
Why the study?
The study aimed to investigate the effect of functional mitral regurgitation on recurrence of paroxysmal atrial fibrillation following radiofrequency catheter ablation.
Does functional mitral regurgitation affect the recurrence of paroxysmal atrial fibrillation in patients undergoing radiofrequency catheter ablation?
Cohort (n=107)
Does functional mitral regurgitation affect the recurrence of paroxysmal atrial fibrillation in patients undergoing radiofrequency catheter ablation?
Functional mitral regurgitation is not an independent risk factor for predicting the recurrence of paroxysmal atrial fibrillation following radiofrequency catheter ablation.
Answers are grounded in this paper and cite their sources.
FMR should not yet guide recurrence risk stratification after PAF ablation; leaves open confirmation in larger prospective studies.
OBJECTIVE: The present study aimed to investigate the effect of functional mitral regurgitation (FMR) on recurrence of paroxysmal atrial fibrillation (PAF) in patients undergoing radiofrequency catheter ablation. METHODS: This prospective cohort study comprised 107 patients with PAF. The patients were divided into the FMR and non-FMR groups. FMR was assessed by Doppler echocardiography before index ablation. All patients initially underwent circumferential pulmonary vein isolation (CPVI) and were followed up for 12 months after ablation. PAF, atrial tachycardia, or atrial flutter served as the endpoint indicator. RESULTS: The median duration of PAF was 24 (3-60) months. Binary logistic univariate and multivariate analyses showed that FMR was not a risk factor for recurrence of catheter ablation for PAF (hazard ratio=0.758, 95% confidence interval: 0.191-3.004; hazard ratio=0.665, 95% confidence interval: 0.134-3.300, respectively). Kaplan-Meier analysis showed no significant difference in the recurrence rate between the groups. Fifteen (15/107, 14%) cases of PAF were triggered by the pulmonary vein. Three (3/107, 2.8%) cases of PAF were triggered by the superior vena cava. CONCLUSIONS: FMR is not an independent risk factor for predicting recurrence of catheter ablation for PAF. FMR does not affect patients undergoing radiofrequency catheter ablation for PAF.
No takes yet. Share an insight, caveat, or question.
Ke et al. (2021) conducted a cohort in paroxysmal atrial fibrillation (n=107). Functional mitral regurgitation (FMR) vs. Non-FMR was evaluated on Recurrence of PAF, atrial tachycardia, or atrial flutter (HR 0.665, 95% CI 0.134-3.300). Functional mitral regurgitation was not an independent risk factor for the recurrence of paroxysmal atrial fibrillation after catheter ablation (multivariate HR 0.665; 95% CI 0.134-3.300).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: